Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
about
Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5'-O-α-Glucopyranoside, a Novel EGCG Derivative.Hydroquinone Exhibits In Vitro and In Vivo Anti-Cancer Activity in Cancer Cells and Mice.A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
P2860
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@en
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@nl
type
label
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@en
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@nl
prefLabel
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@en
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@nl
P2093
P2860
P50
P356
P1476
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
@en
P2093
Alessia Mennitto
Daniela Femia
Laura Concas
Natialie Prinzi
P2860
P304
P356
10.1177/1758834016683905
P577
2017-01-11T00:00:00Z